5/25/2020, 10:58 PM (Source: TeleTrader)
more TeleTrader news


Chart for: Novavax

Novavax to start testing vaccine on humans

Novavax Inc. revealed on Monday that participant enrollment for "a Phase 1/2 clinical trial of its coronavirus vaccine candidate, NVX‑CoV2373," has begun earlier in the day.

The company also said that it anticipates the first trial results of Phase 1 to emerge in July 2020. Phase 1 testing will be conducted in Australia on 130 healthy people of 18 to 59 years of age, while Phase 2 will be carried out in multiple countries, the United States included, and is expected to cover an extended age range.

"Administering our vaccine in the first participants of this clinical trial is a significant achievement, bringing us one step closer toward addressing the fundamental need for a vaccine in the fight against the global COVID‑19 pandemic. We look forward to sharing the clinical results in July and, if promising, quickly initiating the Phase 2 portion of the trial," Novavax's President and CEO Stanley C. Erck (pictured right) said in a press release.

Breaking the News / MS